Xspray Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Xspray Pharma has a total shareholder equity of SEK668.1M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK736.1M and SEK67.9M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 126.57m |
| Equity | SEK 668.14m |
| Total liabilities | SEK 67.93m |
| Total assets | SEK 736.07m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: XSPRAS's short term assets (SEK177.8M) exceed its short term liabilities (SEK38.1M).
Long Term Liabilities: XSPRAS's short term assets (SEK177.8M) exceed its long term liabilities (SEK29.9M).
Debt to Equity History and Analysis
Debt Level: XSPRAS is debt free.
Reducing Debt: XSPRAS has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XSPRAS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: XSPRAS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 21.8% each year